Updates are available Correction dated 2020-06-10
Click to view Correction: https://doi.org/10.1007/s00345-020-03290-0
-
Authors
De Nunzio, Cosimo http://orcid.org/0000-0002-2190-512X
Salonia, Andrea http://orcid.org/0000-0002-0595-7165
Gacci, Mauro http://orcid.org/0000-0001-7877-221X
Ficarra, Vincenzo http://orcid.org/0000-0002-2447-5196
-
Funding
Funding for this research was provided by:
Pierre Fabre Pharma Italy
- License Information
-
More Information
Article History
Received: 10 December 2019
Accepted: 23 January 2020
First Online: 14 February 2020
Change Date: 10 June 2020
Change Type: Correction
Change Details: The article “Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia”, written by Cosimo De Nunzio, Andrea Salonia, Mauro Gacci and Vincenzo Ficarra was originally published electronically on the publisher’s internet portal on 14 February 2020 without open access.
Compliance with ethical standards
:
: C De Nunzio: consultant for Pierre-Fabre, Janssen and Astellas. V Ficarra: honoraria for speaking at symposia from Pierre Fabre and research grants from IDIPharma. M Gacci: company consultant, trial participation, fellowship, travel grant, receipt of grants/research supports for Astellas, Bayer, GSK, Ibsa, Konpharma, Lilly, Menarini, Pierre Fabre and Recordati. A Salonia: no conflict of interest.
